AEON
AEON Biopharma, Inc.
Key Financials
Net Income
$-39222000
↓ 193.4%
Operating Income
$-12803000
↓ 117.5%
EPS (Diluted)
$-3.95
↓ 105.4%
Total Assets
$5.6M
↑ 77.0%
Shareholders' Equity
$-153044000.00
↓ 1521.8%
Cash & Equivalents
$3.0M
↑ 23023.1%
Total Liabilities
$60.6M
↑ 91.1%
Operating Cash Flow
$-17308000.00
↑ 14.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/3/2026 | View on SEC |
| 3 | 4/3/2026 | View on SEC |
| 8-K | 4/3/2026 | View on SEC |
| S-8 | 3/31/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| 4 | 3/11/2026 | View on SEC |
| 8-K | 3/9/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AEON |
| Company Name | AEON Biopharma, Inc. |
| CIK | 1837607 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (949) 354-6499 |